We hereby attaching the board meeting outcome

Acquisition announcedOpen offerStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.8%Reaction day

₹117.50

prior close

₹123.37

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+3.6% vs market

Pharmaceuticals peers, median of 149sector-0.0%+3.9% vs sector

On the reaction day the stock moved 3.6 pts more than Nifty Microcap 250 and 3.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.8+0.3+3.6-0.0+3.9

Next day

+3.8+0.8+3.1+0.5+3.4

+5.5+2.7+2.9+1.4+4.1

+5.6+2.7+2.9+1.3+4.3

+5.5+3.2+2.3+1.7+3.8

+3.0+4.1-1.1+2.7+0.3

-0.4+4.0-4.5+2.1-2.6

15d

-3.4+4.4-7.8+4.0-7.4

-7.2+5.4-12.7+4.3-11.6

-31.1+1.5-32.7-0.8-30.3

-41.4+3.3-44.7+1.5-42.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Oxygenta Pharmaceutical Ltd informed the stock exchange that Virupaksha Organics Limited has successfully completed the open offer and taken over as the new promoter of the company, effective June 20, 2025. Following the takeover, the board was completely reconstituted — 6 new directors (2 executive, 1 non-executive, and 3 independent) were appointed for a 5-year term, while 6 existing directors (3 executive and 3 independent) tendered their resignations citing the change in management. All board committees (Audit, Nomination & Remuneration, Stakeholders' Relationship) were also reconstituted with effect from June 20, 2025.

Likely market impact

This marks a complete change of control at Oxygenta Pharmaceutical, with Virupaksha Organics now as the new promoter — shareholders should expect a strategic shift in business direction under new management. The stock may see volatility around the new leadership; minority shareholders no longer have representation from the old promoter group on the board.